The 21st century is proving to be one of the most exciting and prolific periods of innovation in biosciences and healthcare. Advances across biology, technology, engineering and data science are converging to help create new, potentially life-changing solutions for individuals and societies across the globe. The BIA has identified areas of strategic importance in this new and exciting age of science.
During this relaxed afternoon event we will look at the explainer videos that the BIA have developed and hear from companies within each technology and what exciting new developments are happening in that space. We will also hear from an investor from each technology and hear about why they are excited about investing in that particular space.
Join us in London before our Gala Dinner and take this opportunity to meet up with colleagues and partners for some relaxed networking and learning. We will have space for you to work from 15.00 and change for the Gala Dinner if needed.
30 Crown Place
15.00 Space to hot-desk and work
16.00 Registration and networking
16.15 Introduction to the BIA strategics technologies
16.20 Antimicrobial resistance - Glyn Edwards, Summit Therapeutics and Kate Rowley, BioScience Managers
16.40 Cell and Gene Therapies - John Dawson, Oxford Biomedica and Clare Terlouw, Syncona
17.00 Genomics - David Atkins, Congenica and Alastair Kilgour, Parkwalk
17.20 Engineering Biology - Ted Fjallman, Prokarium and Oliver Sexton, Midven
17.40 Close - networking with drinks and canapes
Free for members and non-members